{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:45Z","timestamp":1794565605709,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515011130"],"award-info":[{"award-number":["2025A1515011130"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82441042"],"award-info":[{"award-number":["82441042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119025","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:25:05Z","timestamp":1780118705000},"page":"119025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of pyrazole-based selective covalent ITK inhibitors with In vivo activity"],"prefix":"10.1016","volume":"316","author":[{"given":"Zhiyang","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4312-7103","authenticated-orcid":false,"given":"Zhengying","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2026.119025_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1359-6101(99)00019-2","article-title":"Tec family of protein-tyrosine kinases: an overview of their structure and function","volume":"10","author":"Mano","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119025_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/08830185.2012.668981","article-title":"Regulation of T-cell responses and disease by tec kinase Itk","volume":"31","author":"August","year":"2012","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119025_bib3","first-page":"145","article-title":"Tec kinases in T cell and mast cell signaling","volume":"vol. 93","author":"Felices","year":"2007"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119025_bib4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.187.10.1721","article-title":"T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells","volume":"187","author":"Liu","year":"1998","journal-title":"J. Exp. Med."},{"issue":"5414","key":"10.1016\/j.ejmech.2026.119025_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1126\/science.284.5414.638","article-title":"Requirement for Tec kinases Rlk and ltk in T cell receptor signaling and immunity","volume":"284","author":"Schaeffer","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119025_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41408-022-00745-y","article-title":"GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms","volume":"12","author":"Geng","year":"2022","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119025_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4049\/jimmunol.174.3.1385","article-title":"Kinase-Independent functions for itk in TCR-Induced regulation of vav and the Actin Cytoskeleton1","volume":"174","author":"Dombroski","year":"2005","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119025_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nri1591","article-title":"TEC-family kinases: regulators of T-helper-cell differentiation","volume":"5","author":"Schwartzberg","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119025_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdermsci.2020.01.013","article-title":"The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway","volume":"97","author":"Li","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"Supplement 1","key":"10.1016\/j.ejmech.2026.119025_bib10","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1182\/blood-2022-159177","article-title":"ITK inhibitor induces dose-dependent Th1 skewing in normal T cells and is active in refractory T cell lymphomas","volume":"140","author":"Song","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119025_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/mol.112.079889","article-title":"Molecular characteristics of CTA056, a novel Interleukin-2-Inducible T-Cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs","volume":"82","author":"Guo","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119025_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12935-019-0754-9","article-title":"ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma","volume":"19","author":"Liu","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"34","key":"10.1016\/j.ejmech.2026.119025_bib13","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1021\/bi049428r","article-title":"Selective Itk inhibitors block T-Cell activation and Murine Lung inflammation","volume":"43","author":"Lin","year":"2004","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119025_bib14","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.bmcl.2006.01.115","article-title":"Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors","volume":"16","author":"Das","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119025_bib15","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/jm101499u","article-title":"Discovery and structure\u2212activity relationship of 3-Aminopyrid-2-ones as potent and selective Interleukin-2 inducible T-Cell kinase (Itk) inhibitors","volume":"54","author":"Charrier","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119025_bib16","series-title":"Preparation of Aminopyrazine Compounds as Itk Inhibitors for Preventing and\/or Treating Atopic Dermatitis","author":"Shetty","year":"2012"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119025_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s44386-024-00002-1","article-title":"Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity","volume":"1","author":"Hsu","year":"2024","journal-title":"npj Drug Discovery"},{"key":"10.1016\/j.ejmech.2026.119025_bib18","first-page":"187","article-title":"Design, synthesis and structure\u2013activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"39","key":"10.1016\/j.ejmech.2026.119025_bib19","doi-asserted-by":"crossref","first-page":"28195","DOI":"10.1074\/jbc.M113.474114","article-title":"Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocket","volume":"288","author":"Harling","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119025_bib20","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1021\/jm301190s","article-title":"Covalent inhibitors of Interleukin-2 inducible T cell kinase (Itk) with nanomolar potency in a whole-blood assay","volume":"55","author":"Zapf","year":"2012","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119025_bib21","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1021\/jm500550e","article-title":"Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors","volume":"57","author":"Burch","year":"2014","journal-title":"J. Med. Chem."},{"issue":"Supplement 1","key":"10.1016\/j.ejmech.2026.119025_bib22","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-778","article-title":"Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed\/refractory (R\/R) T cell lymphomas (TCL)","volume":"146","author":"Miller","year":"2025","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.ejmech.2026.119025_bib24","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1002\/anie.201707875","article-title":"The cysteinome of protein kinases as a target in drug development","volume":"57","author":"Chaikuad","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119025_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chembiol.2012.12.006","article-title":"Developing irreversible inhibitors of the protein kinase cysteinome","volume":"20","author":"Liu","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119025_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejmech.2019.03.055","article-title":"Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk)","volume":"173","author":"Tang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119025_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.it.2006.08.006","article-title":"Itk and Th2 responses: action but no reaction","volume":"27","author":"Kosaka","year":"2006","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119025_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nri1591","article-title":"TEC-family kinases: regulators of T-helper-cell differentiation","volume":"5","author":"Schwartzberg","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119025_bib29","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/jm501998m","article-title":"Tetrahydroindazoles as Interleukin-2 inducible T-Cell kinase inhibitors. Part II. Second-generation analogues with enhanced potency, selectivity, and pharmacodynamic modulation in vivo","volume":"58","author":"Burch","year":"2015","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119025_bib30","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1021\/acs.jmedchem.2c02078","article-title":"Discovery of potent and highly selective Interleukin-2-Inducible T-Cell kinase degraders with in vivo activity","volume":"66","author":"Zhou","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:02:36Z","timestamp":1794564156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S0223523426004708"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119025","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of pyrazole-based selective covalent ITK inhibitors with In vivo activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119025"}}